Nitric oxide: Implications for vascular and endovascular surgery

European Journal of Vascular and Endovascular Surgery

Volumn 22, Issue 4, 2001, Pages 285-293

  Vural, K M ^a   Bayazit, M ^a  

^a TURKIYE YUKSEK IHTISAS HOSPITAL   (Turkey)

Author keywords

Endovascular; Homeostasis; Nitric oxide; Stents; Synthetic grafts; Vascular surgery

Indexed keywords

ACETYLCHOLINE; ANTITHROMBOCYTIC AGENT; ARGININE; BRADYKININ; LINSIDOMINE; MOLSIDOMINE; NITRIC OXIDE; NITRIC OXIDE DONOR; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR; PROSTACYCLIN; PROTECTIVE AGENT; SPERMINE DERIVATIVE; TRANSFORMING GROWTH FACTOR BETA; VASCULAR CELL ADHESION MOLECULE 1; VASCULOTROPIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERY INTIMA PROLIFERATION; ATHEROSCLEROSIS; BYPASS SURGERY; CHEMICAL ANALYSIS; CLINICAL PRACTICE; CONTROLLED STUDY; DRUG ACTIVITY; ENDOVASCULAR SURGERY; FIBRINOLYSIS; GENE THERAPY; HOMEOSTASIS; HUMAN; NONHUMAN; PATHOPHYSIOLOGY; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; RESTENOSIS; REVIEW; STENT; SYNTHESIS; VASCULAR DISEASE; VASCULAR SMOOTH MUSCLE;

EID: 0034807966     PISSN: 10785884     EISSN: None     Source Type: Journal    
DOI: 10.1053/ejvs.2001.1448     Document Type: Review

References (80)

1. Nitric Oxide and the cardiovascular system
2. Nitric oxide: Physiology, pathophysiology, and pharmacology
3. Reactions of the bioregulatory agent nitric oxide in oxygenated aqueous media: Determination of the kinetics for oxidation and nitrosation by intermediates generated in the N0/02 reaction
4. S-nitrosocysteine inhibition of human platelet secretion is correlated with increases in platelet cGMP levels
5. Evidence for a cyclic GMP-independent mechanism in the anti-platelet action of S-nitrosoglutathione
6. L-Arginine is the physiological precursor for the formation of nitric oxide in endothelium dependent relaxation
7. Localization of neuronal nitric oxide synthase
8. Nitric oxide synthase in models of focal ischemia
9. Prolonged in vivo hypoxia enhances nitric oxide synthase type I and type III gene expression in adult rat lung
10. Food or water deprivation modulates nitric oxide synthase (NOS) activity and gene expression in rat hypothalamic neurons: Correlation with neurosecretory activity?
11. Up-regulation of nitric oxide synthase messenger RNA in an integrated forebrain circuit involved in oxytocin secretion
12. Characterization and localization of endothelial nitric oxide synthase using specific monoclonal antibodies
13. In situ identification of messenger RNA of endothelial type nitric oxide synthase in rat cardiac myocytes
14. Expression and regulation of endothelial nitric oxide synthase
15. Molecular cloning and characterization of the constitutive bovine aortic endothelial cell nitric oxide synthase
16. Chronic exercise in dogs increases coronary vascular nitric oxide production and endothelial cell nitric oxide synthase gene expression
17. 1
18. Molecular biology of nitric oxide synthases
19. Endothelial adhesivity, pulmonary hemodynamics and nitric oxide synthesis in ischemia-reperfusion
20. Effects of mast cell membrane stabilizing agents in a rat lung ischemia-reperfusion model
21. Location of an inducible nitric oxide synthase mRNA in the normal kidney
22. Role of nitric oxide in autocrine control of growth and apoptosis of endothelial cells
23. Superoxide anions and hyperoxia inactivate endothelium-derived relaxing factor
24. The role of nitric oxide and other endothelium-derived vasoactive substances in vascular disease
25. Mechanical deformation of vessel wall and shear stress determine the basal release of endothelium-derived relaxing factor in the intact rabbit coronary vascular bed
26. Interactions between nitric oxide and prostacyclin
27. Transfection of inducible nitric oxide synthase gene causes apoptosis in vascular smooth muscle cells
28. Nitric oxide synthesis inhibition increases epithelial permeability via mast cells
29. Role of endothelium-derived nitric oxide in the bleeding tendency of uremia
30. High-output nitric oxide: Weapon against infection?
31. The altered tumoricidal capacity of macrophages isolated from tumor-bearing mice is related to reduce expression of the inducible nitric oxide synthase gene
32. Effects of redox-related congeners on apoptosis and caspase-3 activity
33. Suppression of apoptosis by nitric oxide via inhibition of ICE-like and CPP32-like proteases
34. Reciprocal relation between VEGF and NO in the regulation of endothelial integrity
35. Adventitial remodeling after coronary arterial injury
36. Modulation of rat mast cell reactivity by IL-1 beta. Divergent effects on nitric oxide and platelet-activating factor release
37. Membrane stabilization in harvested vein graft storage: Effects on adhesion molecule expression and nitric oxide synthesis
38. Low basal and stimulated release of nitric oxide in atherosclerotic epicardial coronary arteries
39. Atherosclerosis-an inflammatory disease
40. Abrupt coronary artery occlusion during percutaneous transluminal coronary angioplasty
41. Restenosis after coronary angioplasty. A multivariate statistical model to relate lesion and procedure variables to restenosis
42. Intracoronary stenting for acute and threatened closure complicating percutaneous transluminal coronary angioplasty
43. Early platelet deposition and distribution in various graft materials
44. Blood in Contact with Natural and Artificial Surfaces
45. The effects of exogenous nitric oxide on smooth muscle cell proliferation following porcine carotid angioplasty
46. SIN-1 reduces platelet adhesion and platelet thrombus formation in a porcine model of balloon angioplasty
47. Effect of the direct nitric oxide donors linsidomine and molsidomine on angiographic restenosis after coronary balloon angioplasty
48. Inhibition of neointimal proliferation in rabbits after vascular injury by a single treatment with a protein adduct of nitric oxide
49. Inhaled nitric oxide as a cause of selective pulmonary vasodilation in pulmonary hypertension
50. L-arginine induces nitric oxide-dependent vasodilation in patients with critical limb ischemia. A randomized, controlled study
51. Biochemical evidence for impaired nitric oxide synthesis in patients with peripheral arterial occlusive disease
52. Treatment with L-arginine is likely to stimulate generation of nitric oxide in patients with peripheral arterial obstructive disease
53. Dose-related effect of intravenous L-arginine on muscular blood flow of the calf in patients with peripheral vascular disease: A H215O positron emission tomography study
54. Long-term smoking impairs platelet-derived nitric oxide release
55. Evidence for altered platelet nitric oxide synthesis in essential hypertension
56. Long-term oral administration of L-arginine reduces intimal thickening and enhances neoendothelium-dependent acetycholine-induced relaxation after arterial injury
57. Gene therapy inhibiting neointimal vascular lesion: In vivo transfer of endothelial cell nitric oxide synthase gene
58. Overexpression of human endothelial nitric oxide synthase in rat vascular smooth muscle cells and in balloon-injured carotid artery
59. Perivascular iNOS gene transfer using a novel non-occlusive gene delivery device inhibits intimal hyperplasia
60. Human endothelial nitric oxide synthase gene transfer inhibits vascular smooth muscle cell proliferation and neointima formation after balloon injury in rats
61. Localizing antithrombotic and vasodilatory activity with a novel, ultrafast nitric oxide donor
62. Boundary layer infusion of nitric oxide reduces early smooth muscle cell proliferation in the endarterectomized canine artery
63. A nitric oxide donor (spermine-NONOate) prevents the formation of neointima in rabbit carotid artery
64. Perivascular delivery of a nitric oxide donor inhibits neointimal hyperplasia in vein grafts implanted in the arterial circulation
65. Nitric oxide-releasing polymers containing the [N(O)NO]- group
66. Nitric oxide donors: A continuing opportunity in drug design
67. Incorporation of nitric oxide-releasing crosslinked polyethyleneimine microspheres into vascular grafts
68. Coronary stenting with polymer-coated and uncoated self-expanding endoprotheses in pigs
69. Seeding of intravascular stents with genetically engineered endothelial cells
70. Polymeric stenting in the porcine coronary artery model: Differential outcome of exogenous fibrin sleeves versus polyurethane-coated stents
71. Reduction in thrombotic events with heparin-coated Palmaz-Schatz stents in normal porcine coronary arteries
72. Protein interactions with artificial surfaces
73. Effect of albumin immobilization by plasmapolymerization on platelet reactivity
74. Acute surface-induced thrombosis in the canine ex vivo model: Importance of protein composition of the initial monolayer and platelet activation
75. Study on the prevention of surface induced platelet activation by albumin coating
76. S-nitrosylation of proteins with nitric oxide: Synthesis and characterization of biologically active compounds
77. Coating Palmaz-Schatz stents with a unique NO donor reduces the need for post-procedure anticoagulation when placed in pig carotid arteries
78. Local delivery of nitrosated albumin to stenosed and damaged coronary arteries inhibits platelet deposition and thrombosis
79. NO forms a stable adduct with serum albumin that has potent antiplatelet properties in vivo
80. The potent platelet inhibitory effect of S-nitrosated albumin coating of artificial surfaces